|
Brucellosis vaccines
|
J07AD |
|
|
meclofenamic acid
|
M02AA18 |
|
|
immunoglobulins, normal human, for extravascular adm.
|
J06BA01 |
|
|
Protectives against UV-radiation for systemic use
|
D02BB |
|
|
ecallantide
|
B06AC03 |
|
|
mannitol
|
B05CX04 |
|
|
icatibant
|
B06AC02 |
|
|
bufexamac
|
M02AA09 |
|
|
Protectives against UV-radiation for topical use
|
D02BA |
|
|
conestat alfa
|
B06AC04 |
|
|
DOPAMINERGIC AGENTS
|
N04B |
|
|
c1-inhibitor, plasma derived
|
B06AC01 |
|
|
atropine
|
A03BA01 |
|
|
belladonna total alkaloids
|
A03BA04 |
|
|
ANTICHOLINERGIC AGENTS
|
N04A |
|
|
Other emollients and protectives
|
D02AX |
|
|
hyoscyamine
|
A03BA03 |
|
|
glucose
|
B05CX01 |
|
|
sorbitol
|
B05CX02 |
|
|
glycine
|
B05CX03 |
|
